Part I – (this draws on opportunity cost (Ch 1) and markets (Ch 3)). Describe the market for kidney organs, as it would be in a free market without government intervention, using what you have learned about scarcity, marginal analysis in decision-making, and markets. You must include a discussion of resources, supply and demand, as well as marginal benefits and marginal costs. Think of this as an explanation of the pros and cons of the market using specific economic terminology and concepts learned in this course. Describe the benefits and costs but leave the discussion of organ rationing and other solutions to the problems in this market for the next part. Describe this market using the supply and demand graphical model; reference your graph in your description. Include “graph 1” of this market at the end of the paper in an appendix (not included in page count). This should be a discussion without mentioning Price Controls, only discuss how the kidney organ market would be without government intervention. Feel free to use any stats or data that you find through your own research – make sure you use multiple different economic terms from key concepts in chapters 1 and 3 throughout this part of the paper or you will not earn a complete on this assignment. Each individual student is required to determine what graph they would like to use in their analysis to describe the situation above; the graph can be created by the students or found through other sources as long as proper citation in provided.
Part II – (this draws on government (Ch 4) to improve the discussion made in Part I). Consider the reasons why the market for kidney organs is not a free market in the US, specifically discuss equity concerns. Expand on your discussion of the market from Part I, using what you have learned about government interventions/price controls. Discuss the current government intervention in the Kidney Market in the U.S. Describe this market – comparing the free market and to the government intervention in a graph – add to the supply and demand graphical model “graph 1” OR include a separate supply and demand graphical model “graph 2” or you will not earn a complete on this assignment; reference and discuss your graph in your paper. Explain the current government intervention and exactly how it corrects the problems of the free market. Include any other beneficial aspects of the intervention that you find through your own research – make sure you use multiple different economic terms from key concepts chapter 4 throughout this part of the paper or you will not earn a complete on this assignment. Each individual student is required to determine what graph they would like to use in their analysis to describe the situation above; the graph can be created by the students or found through other sources as long as proper citation in provided.
Also discuss other Donation Systems Around the World, no need to add a graph here. Explore the policies that are currently implemented across the globe (i.e. some discussed in the articles include – routine removal, presumed consent, organ donor points: “no give, no take”, etc.). Evaluate the limitations of these policies. Also consider how these policies fare in terms of the efficiency in equity debate. (You do not need to critique them all, just select from 2 or 3 different countries that you find interesting/appealing)
The correct answer and explanation is:
Part I: The Free Market for Kidney Organs
A free market for kidney organs would operate like any other market driven by supply and demand without government intervention. This means that the price of kidneys would be determined by the equilibrium between the quantity supplied by willing donors and the quantity demanded by patients needing transplants. However, the kidney market differs from traditional goods because of the ethical concerns, scarcity of the resource, and potential negative externalities.
Scarcity and Opportunity Cost
Kidneys are a scarce resource because they are essential for survival and cannot be mass-produced. Given that each individual has two kidneys but requires only one to live, the opportunity cost of donating a kidney is the potential health risk and long-term medical costs associated with having only one kidney. This means that potential sellers must weigh the marginal benefit of receiving monetary compensation against the marginal cost of the health risks and recovery period.
Supply and Demand
In a free market, individuals willing to sell their kidneys would represent the supply, while those needing transplants would represent the demand. The supply curve would be upward-sloping because as prices increase, more people would be willing to sell their kidneys. The demand curve, on the other hand, would be downward-sloping since fewer people would demand kidneys at higher prices.
Without regulation, the equilibrium price would be determined by the intersection of the supply and demand curves. Given the high demand for kidneys due to chronic kidney disease and other medical conditions, and the limited willingness of individuals to sell their kidneys, the price would likely be high. This means that wealthier individuals would have better access to kidneys, creating concerns about equity.
Marginal Analysis
From the perspective of donors, the marginal benefit of selling a kidney is the financial compensation they receive, while the marginal cost includes the surgical procedure, health risks, and potential reduction in life expectancy. For buyers, the marginal benefit is the improved quality and length of life gained from the transplant, while the marginal cost is the price paid for the kidney.
Since kidneys have no close substitutes and their demand is relatively inelastic, buyers may be willing to pay high prices, leading to potential price gouging. On the supply side, potential donors with lower incomes might be more willing to sell their kidneys due to financial necessity, creating ethical dilemmas about exploitation.
Graphical Representation (Graph 1)
The market equilibrium in a free market can be represented using a supply and demand model, where the price (P) of kidneys is on the vertical axis and the quantity (Q) of kidneys on the horizontal axis. The equilibrium price and quantity would be determined by the intersection of the supply and demand curves.
Part II: Government Intervention in the Kidney Market
The U.S. government prohibits the sale of human organs, meaning the kidney market is not a free market. Instead, it relies on a donation-based system regulated by the National Organ Transplant Act (NOTA), which makes it illegal to buy or sell organs. This intervention exists primarily due to concerns about equity, ethical considerations, and potential exploitation of vulnerable populations.
Equity Concerns and Government Regulation
A completely unregulated kidney market would create significant disparities, as only those who can afford kidneys would receive transplants, leaving lower-income individuals without access to life-saving procedures. To promote equity, the government ensures that organ allocation is based on medical need rather than financial status. The current system distributes kidneys based on priority criteria such as waiting time, compatibility, and urgency rather than purchasing power.
To address scarcity, the government promotes organ donation through various programs, including opt-in registration and living donor incentives (such as covering medical costs for donors). However, despite these efforts, the demand for kidneys far exceeds the supply, leading to long waitlists and preventable deaths.
Comparison Between Free Market and Government Intervention
In a regulated system, the price of kidneys is set at zero because buying and selling are illegal. This results in excess demand, as more patients need kidneys than there are available donors. The supply curve remains limited, leading to shortages and long waiting lists. A graph comparing the free market (Graph 1) and the regulated market (Graph 2) would show how the intervention sets the price at zero, leading to a persistent gap between demand and supply.
While government intervention addresses ethical concerns and equity issues, it also results in inefficiencies, as a price-controlled system eliminates financial incentives that could encourage more donations. Some argue that compensation-based systems, such as reimbursing donors for expenses or providing other incentives, could help alleviate shortages.
Donation Systems Around the World
Several countries have experimented with different organ donation policies to address shortages. Below are three notable systems:
1. Presumed Consent (Spain)
Spain follows a presumed consent system, meaning that unless individuals explicitly opt out, they are considered organ donors upon death. This policy has led to one of the highest organ donation rates in the world. The benefit is that it significantly increases the supply of kidneys, reducing waiting times. However, presumed consent alone does not guarantee higher donation rates if not supported by adequate healthcare infrastructure and public trust.
2. No Give, No Take (Israel)
Israel has implemented a priority system known as “no give, no take,” where individuals who register as organ donors receive priority if they ever need an organ transplant in the future. This creates an incentive to register as a donor while maintaining an ethical allocation system. However, critics argue that it may disadvantage those who were unaware of the policy or unable to register in time.
3. Compensation-Based System (Iran)
Iran is the only country that allows financial compensation for kidney donors under government regulation. This has virtually eliminated kidney waitlists. Donors receive a fixed payment from the government and additional compensation from the recipient. While this system has successfully addressed shortages, critics argue that it disproportionately incentivizes lower-income individuals to donate, raising ethical concerns about exploitation.
Conclusion
The market for kidney organs in a free market would lead to high prices and an imbalance in access due to income disparities. Government intervention seeks to promote equity but results in inefficiencies due to persistent shortages. Different global models provide alternative approaches, but each system has trade-offs between efficiency and fairness. Future solutions may involve hybrid systems that incorporate incentives while maintaining ethical standards.
Appendix
Graph 1: Free Market Kidney Market (Supply and Demand)
Graph 2: Government-Regulated Kidney Market (Supply and Demand with Price Control)
Would you like me to generate the supply and demand graphs for you?